The Verisian Community Podcast

Description Andrew York has over 30 years experience as a statistical programmer and biostatistician. From the beginning of his career as a statistician at Roche, to his current role as Clinical Data Science Vice President at Novo Nordisk, Andy has seen the industry evolve and has played a leading role in shaping best practice in the industry. Reflecting on these experiences, in this episode Andy...

Description Josef von Rickenbach is a true pioneer in the pharmaceutical industry. In 1982, he co-founded Parexel, a company that would go on to define the CRO industry as we know it today. Over the next 36 years as CEO, he led over 40 acquisitions, scaled the company to 19,000 employees, and helped set industry standards that still shape biopharma today. But Josef’s story isn’t just about busines...

Episode Summary Double programming has long been the industry standard for validation in statistical programming, but is it the most effective approach? In this episode, Henning Kuich, Richardus Vonk, Sunil Gupta and Tomás Sabat Stöfsel discuss how code traceability is transforming the validation process, enhancing transparency, improving efficiency, reducing costs and enabling better collaboratio...

Episode Summary In this episode, we sit down with David, an expert in R programming for clinical trials, to discuss the evolving landscape of statistical programming. From his unconventional journey from journalism and philosophy into programming to his deep insights on the maintainability and stability of R in the pharmaceutical industry, David shares his perspective on the challenges and opportu...

Episode Summary In this episode of the Verisian Community Podcast, Katja explores the huge potential of open-source tools in clinical development. She discusses how platforms like OpenStudyBuilder are revolutionizing study design and collaboration within the pharma industry. Katja shares her experiences in overcoming resistance to open-source adoption, addressing challenges like regulatory constra...

Episode Summary In this episode, Shafi discusses his decades-long journey and what led him into the world of statistical programming. He shares insights into the evolution of automation in clinical trials, its role in transforming traditional tasks like validation and double programming, and the impact AI is having on oversight and traceability for large teams. Shafi also addresses the ongoing cha...

Episode Summary In this episode, Nijat from Lindus Health shares their vision for building the future of clinical trials by creating what they call the "anti-CRO." He dives into Lindus Health's mission and his personal passion for driving change in this space. Nijat explores the challenges of innovation in clinical trials, particularly the complexity of aligning trials with patient needs while nav...

Episode Summary In this episode of the Verisian Community Podcast, we welcome Sunil Kumar Pusarla to share his journey and insights from over 20 years in statistical programming. Sunil discusses the skills and traits essential for success as a statistical programmer, addressing the challenges and pressures that professionals face today. He emphasizes the importance of maintaining high-quality stan...

Episode Summary In this episode of the Verisian Community Podcast, Richardus Vonk discusses the transformative role of AI in clinical trials. He explores how AI is reshaping trial planning and execution, improving early disease detection like cancer, and the challenges it still faces in drug development. Richardus also highlights the benefits of automation in freeing up time for deeper scientific...

Episode Summary In this episode of the Verisian Community Podcast, we welcome Ricardo Baeza-Yates, a renowned computer scientist, to discuss the world of Large Language Models (LLMs) and their implications. Ricardo delves into the mechanics of LLMs, their popularity, and the challenges they pose. He discusses the inherent lack of reasoning and understanding in LLMs, explores the limitations in rep...

Episode Summary In this episode of the Verisian Community Podcast, we welcome Daniel Rolo, Director of Statistical Programming at Parexel to discuss the evolving landscape of statistical programming. Daniel addresses the shift from traditional tools like SAS to modern languages such as Python and R, emphasizing the response to increasing data complexity and the rise of open-source platforms and AI...

Episode Summary In this Verisian Community Podcast episode, we welcome Ritika Aggarwal from Novartis, who shares insights on the evolving landscape of statistical programming. Addressing challenges like data complexity and the rise of AI, Ritika frames these as opportunities for innovation. We touch on the industry's adaptation to the "new normal," the crucial role of continuous learning for progr...

Episode Summary In this episode of the Verisian Community Podcast, we're thrilled to welcome Mansi Thakrar, a Statistical Programmer at Massachusetts General Hospital. This marks our second installment dedicated to discussing good programming practices, where Mansi shares her insights into what constitutes good statistical code in biostatistics. Additionally, we delve into the challenges and oppor...

Episode Summary In this episode of the Verisian Community Podcast, we welcome Shadab from Merck and Rahul from Johnson & Johnson. Our conversation begins with a discussion on the feasibility and desirability of achieving end-to-end automation in the realm of clinical programming. We then delve into the world of generative AI, exploring its potential to revolutionize existing workflows. To wrap...

Episode Summary In this episode of the Verisian Community Podcast, we welcome Cornelia from Bayer, to discuss good programming practice in clinical programming. Cornelia highlights the critical aspects of writing good SAS code and adapting to languages such as R. Cornelia delves into how Bayer is embracing AI in clinical programming and emphasizes the pivotal role of maintaining high standards in...

Episode Summary In this episode of the Verisian Community Podcast, Kyle (Syneos) and Oliver (Bayer) discuss the challenges and opportunities of open source in clinical analysis. They look at the importance of people and communication within the industry and the need for a culture change before embracing new systems. They also explore the potential of AI in clinical analysis, highlighting its benef...

Episode Summary In the first episode of the Verisian Community Podcast, Tomás and Henning, along with industry expert Sunil, discuss how new technology can improve the world of statistical programming. They look at how the Verisian Validation Engine ensures programmers can guarantee the integrity of their analyses. The discussion navigates through the evolution of data analytics cas, the potential...